A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL
Condition(s):Diffuse Large B-cell LymphomaLast Updated:June 1, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Diffuse Large B-cell LymphomaLast Updated:June 1, 2023Not yet recruiting
Condition(s):Diffuse Large B-Cell LymphomaLast Updated:December 18, 2023Recruiting
Condition(s):Refractory Diffuse Large B-cell LymphomaLast Updated:April 23, 2021Not yet recruiting
Condition(s):LymphomaLast Updated:February 20, 2012Completed
Condition(s):Lymphoma, Diffuse Large B-CellLast Updated:June 29, 2023Completed
Condition(s):Diffuse Large B Cell Lymphoma; Chronic Lymphocytic Leukemia; Non Hodgkin LymphomaLast Updated:August 4, 2022Recruiting
Condition(s):Diffuse Large-cell B-cell LymphomaLast Updated:May 9, 2023Terminated
Condition(s):Mantle Cell Lymphoma; B Cell Lymphoma; Multiple MyelomaLast Updated:March 15, 2013Completed
Condition(s):LymphomaLast Updated:January 23, 2018Completed
Condition(s):Diffuse Large B-cell LymphomaLast Updated:November 25, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.